A carregar...
Choosing first line therapy for chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) exhibits a highly variable natural history, but the addition of genomic risk stratification to traditional clinical staging systems has begun to explain the heterogeneous clinical course. Overall response to treatment has significantly improved over the past three...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341916/ https://ncbi.nlm.nih.gov/pubmed/21929312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/era.11.132 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|